Hims & Hers stock sees another spike in trading
Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.
Hims & Hers Health (HIMS) saw its shares surge in the last session with trading volume being higher than average. The latest ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results